About: covid:PMC6759245

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC6759245 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Drosten, Christian Sieberg, Andrea Müller, Marcel Harvey, Ruth Hassall, Mark Mattiuzzo, Giada Rigsby, Peter Oxenford, Christopher
is schema:about of	named entity 'SEROLOGIC' named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS' named entity 'COMPARISON' named entity 'MERS-CoV' named entity 'antibody response' named entity 'immune response' named entity 'MERS-CoV' named entity 'vaccine' named entity 'diagnostic tests' named entity 'antibody' named entity 'South Korea' named entity 'clinical studies' named entity 'China' named entity 'antibody' named entity 'South Mimms' named entity 'Korea' named entity 'HCoV-OC43' named entity 'plasma' named entity 'MERS-CoV' named entity 'recombinant' named entity 'Public Health England' named entity 'IgG' named entity 'vaccines' named entity 'MERS-CoV' named entity 'Hong Kong' named entity 'serologic' named entity 'preclinical' named entity 'immunofluorescence' named entity 'Netherlands' named entity 'Seoul' named entity 'South Korea' named entity 'plasma' named entity 'London' named entity 'informed consent' named entity 'United States' named entity 'Center for Disease Control and Prevention' named entity 'infection' named entity 'serum samples' named entity 'IgG' named entity 'infectious diseases' named entity 'Oman' named entity 'Microbiology' named entity 'clinical trials' named entity 'immunofluorescence assay' named entity 'serology' named entity 'Infectious Diseases' named entity 'MERS' named entity 'Saudi Arabia' named entity 'spike protein' named entity 'Berlin' named entity 'Germany' named entity 'antibodies' named entity 'serology' named entity 'National Institute for Biological Standards and Control' named entity 'TCID50' named entity 'Korea Centers for Disease Control and Prevention' named entity 'virus' named entity 'spike protein' named entity 'positive or negative' named entity 'emerging pathogens' named entity 'MERS-CoV' named entity 'Germany' named entity 'TCID50' named entity 'human coronavirus' named entity 'laboratory testing' named entity 'antibodies' named entity 'coronaviruses' named entity 'Sioux Falls, SD' named entity 'plasma' named entity 'detergent' named entity 'MERS-CoV' named entity 'laboratory testing' named entity 'MERS-CoV' named entity 'titer' named entity 'Infectious Diseases' named entity 'nucleoprotein' named entity 'University of Hong Kong' named entity 'recombinant' named entity 'MERS-CoV' named entity 'protein' named entity 'IgG' named entity 'antibody' named entity 'virus' named entity 'L. Zhao' named entity 'plasma' named entity 'China' named entity 'South Korea' named entity 'antibodies' named entity 'Australia' named entity 'virus' named entity 'R. Gopal' named entity 'NIBSC'

Attributes

Values

Creator

Drosten, Christian
Sieberg, Andrea
Müller, Marcel
Harvey, Ruth
Hassall, Mark
Mattiuzzo, Giada
Rigsby, Peter
Oxenford, Christopher

is schema:about of

named entity 'SEROLOGIC'
named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS'
named entity 'COMPARISON'
named entity 'MERS-CoV'
named entity 'antibody response'
named entity 'immune response'
named entity 'MERS-CoV'
named entity 'vaccine'
named entity 'diagnostic tests'
named entity 'antibody'
named entity 'South Korea'
named entity 'clinical studies'
named entity 'China'
named entity 'antibody'
named entity 'South Mimms'
named entity 'Korea'
named entity 'HCoV-OC43'
named entity 'plasma'
named entity 'MERS-CoV'
named entity 'recombinant'
named entity 'Public Health England'
named entity 'IgG'
named entity 'vaccines'
named entity 'MERS-CoV'
named entity 'Hong Kong'
named entity 'serologic'
named entity 'preclinical'
named entity 'immunofluorescence'
named entity 'Netherlands'
named entity 'Seoul'
named entity 'South Korea'
named entity 'plasma'
named entity 'London'
named entity 'informed consent'
named entity 'United States'
named entity 'Center for Disease Control and Prevention'
named entity 'infection'
named entity 'serum samples'
named entity 'IgG'
named entity 'infectious diseases'
named entity 'Oman'
named entity 'Microbiology'
named entity 'clinical trials'
named entity 'immunofluorescence assay'
named entity 'serology'
named entity 'Infectious Diseases'
named entity 'MERS'
named entity 'Saudi Arabia'
named entity 'spike protein'
named entity 'Berlin'
named entity 'Germany'
named entity 'antibodies'
named entity 'serology'
named entity 'National Institute for Biological Standards and Control'
named entity 'TCID50'
named entity 'Korea Centers for Disease Control and Prevention'
named entity 'virus'
named entity 'spike protein'
named entity 'positive or negative'
named entity 'emerging pathogens'
named entity 'MERS-CoV'
named entity 'Germany'
named entity 'TCID50'
named entity 'human coronavirus'
named entity 'laboratory testing'
named entity 'antibodies'
named entity 'coronaviruses'
named entity 'Sioux Falls, SD'
named entity 'plasma'
named entity 'detergent'
named entity 'MERS-CoV'
named entity 'laboratory testing'
named entity 'MERS-CoV'
named entity 'titer'
named entity 'Infectious Diseases'
named entity 'nucleoprotein'
named entity 'University of Hong Kong'
named entity 'recombinant'
named entity 'MERS-CoV'
named entity 'protein'
named entity 'IgG'
named entity 'antibody'
named entity 'virus'
named entity 'L. Zhao'
named entity 'plasma'
named entity 'China'
named entity 'South Korea'
named entity 'antibodies'
named entity 'Australia'
named entity 'virus'
named entity 'R. Gopal'
named entity 'NIBSC'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software